Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Expanding Oncology Expertise in West Tennessee

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute, the Midsouth’s  leader in adult cancer care, has expanded radiation oncology services with the acquisition of Cancer Care Center’s Dyersburg and Jackson locations, and Paris location in partnership with Henry County Medical Center.   West is known for providing outstanding cancer care with novel therapies, access to clinical trials… Read more »

Welcome, Dr. Mihaela Onciu

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute is proud to welcome Mihaela Onciu, MD, to our Division of Pathology. Dr. Onciu brings over 20 years of pathologic evaluation experience to our network including that of bone marrow, peripheral blood and tissue samples for benign and malignant hematologic disorders. Having worked in both academic and national reference… Read more »

West Cancer Center, Memphis Breast Cancer Consortium and Rabble Health Announce Initial Results Of Care Pathway Initiative

Posted by & filed under Uncategorized.

Results from a partnership to address disparities and enhance the quality of breast cancer care at Memphis-based West Cancer Center & Research Institute were announced today. The program is sponsored by Amgen. “Our goal is to reduce breast cancer-related mortality disparity rates of Black women in the Memphis area, where the current disparity rate is approximately 70 percent –… Read more »

West Joins ‘Advancing Inclusive Research’ Site Alliance

Posted by & filed under Uncategorized.

West Cancer Center, Memphis, Tennessee; City of Hope Comprehensive Cancer Center, Duarte, California; Mays Cancer Center, home to UT Health San Antonio MD Anderson, San Antonio, Texas; O’Neal Comprehensive Cancer Center, and University of Alabama at Birmingham, Birmingham, Alabama; comprise the new Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites aims to advance the representation… Read more »

Vaccine Therapy to Prevent Recurrences in HER2-Positive Breast Cancer

Posted by & filed under Uncategorized.

Breast Cancer Medical Oncologist, Dr. Lee Schwartzberg, shares information on recent studies regarding vaccine therapy to prevent recurrences in #HER2-positive #breastcancer. During a PracticeUpdate interview, Schwartzberg states “We’ve been looking at cancer vaccines for many years now and one of the strategies has particularly been for HER2-positive breast cancers, and it continues to develop as… Read more »

West and Saint Francis Healthcare Announce Joint Relationship

Posted by & filed under Uncategorized.

West Cancer Center and Saint Francis Healthcare Announce Joint Relationship New affiliation includes first-in-the-Mid-South cancer urgent care center     West Cancer Center and Research Institute and Saint Francis Healthcare today announced an agreement to advance and increase access to cancer care in the Mid-South. This collaboration is supported by multi-million dollar investments in cancer… Read more »

WEST FIGHT ON

Posted by & filed under Uncategorized.

​West Fight On returns to Shelby Farms Park on September 11, 2021   Get ready to cycle, run, or walk to beat cancer! West Fight On benefiting West Cancer Foundation will be LIVE and IN-PERSON this September!   This signature fundraising event will return to its home at Shelby Farms Park on Saturday, September 11,… Read more »

Dr. Daniel Vaena Co-Presented Data from Phase I Study at ASCO 2021

Posted by & filed under Uncategorized.

Dr. Daniel Vaena, Director of Experimental Therapeutics Program at West Cancer Center Research Institute, co-presented updated data from Compugen Ltd.’s Phase 1 dose escalation and expansion study of COM701 as a monotherapy, and in a dose escalation combination study with Opdivo® (nivolumab)   Vaena states “Although these results are very preliminary, they suggest that targeting… Read more »

X